Impact of cows' milk estrogen on cancer risk

International Dairy Journal

Volumn 22, Issue 1, 2012, Pages 3-14

  Parodi, Peter W ^a  

^a Human Nutrition and Health Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCEPTABLE DAILY INTAKES; CANCER RISK; COMPLEX MECHANISMS; COWS' MILK; GASTROINTESTINAL TRACT; IN-SITU SYNTHESIS; PRODUCT CONSUMPTION;

DAIRY PRODUCTS; DISEASES;

DAIRIES;

EID: 82655162061     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2011.08.006     Document Type: Review

References (146)

1. Adlercreutz H., Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. Journal of Steroid Biochemistry 1980, 13:231-244.
2. Adlercreutz H., Martin F., Jarvenpaa P., Fotsis T. Steroid absorption and enterohepatic recycling. Contraception 1979, 20:201-223.
3. Andersson A.-M., Skakkebaek N.E. Exposure to exogenous estrogens in food: possible impact on human development and health. European Journal of Endocrinology 1999, 140:477-485.
4. Arslan A.A., Shore R.E., Afanasyeva Y., Koenig K.L., Toniolo P., Zeleniuch-Jacquotte A. Circulating estrogen metabolites and risk of breast cancer in premenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2009, 18:2273-2279.
5. Bandera E.V., Kushi L.H., Moore D.F., Gifkins D.M., McCullough M.L. Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Causes Control 2007, 18:967-988.
6. Bernstein L., Ross R.K. Endogenous hormones and breast cancer risk. Epidemiologic Reviews 1993, 15:48-65.
7. Berrino F., Bellati C., Secreto G., Camerini E., Pala V., Panico S., et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the Diet and Androgens (DIANA) Randomized Trial. Cancer Epidemiology, Biomarkers and Prevention 2001, 10:25-33.
8. Bosland M.C. Sex steroids and prostate carcinogenesis. Annals of the New York Academy of Sciences 2004, 1089:168-176.
9. Bradlow H.I., Telang N.T., Sepkovic D.W., Osborne M.P. 2-Hydroxyestrone: the "good" estrogen. Journal of Endocrinology 1996, 150:S259-S265.
10. Brinkman M.T., Baglietto L., Krishnan K., English D.R., Severi G., Morris H.A., et al. Consumption of animal products, their nutrient components and postmenopausal circulating steroid hormone concentrations. European Journal of Clinical Nutrition 2010, 64:176-183.
11. Capper J.L., Cady R.A., Bauman D.E. The environmental impact of dairy production: 1944 compared with 2007. Journal of Animal Science 2009, 87:2160-2167.
12. Carr B.R., Bradshaw K.D. Disorders of the ovary and female reproductive tract. Harrison's principles of internal medicine 1998, Vol. 2:2097-2115. McGraw-Hill, New York. NY, USA, Ch. 337. 14th ed. A.S. Fauci (Ed.).
13. Carruba G., Granata O.M., Pala V., Campisi I., Agostara B., Cusimano R., et al. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutrition and Cancer 2006, 56:253-259.
14. Castagnetta L.A.M., Granata O.M., Traina A., Ravizzolo B., Amoroso M., Miele M., et al. Tissue content of hydroxy estrogens in relation to survival of breast cancer patients. Clinical Cancer Research 2002, 8:3146-3155.
15. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. Journal of the National Cancer Institute Monographs 2000, 27:75-93.
16. Cavalieri E.L., Devanesan P., Bosland M.C., Badawi A.F., Rogan E.G. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23:329-333.
17. Cavalieri E.L., Li K.-M., Balu N., Saeed M., Devanesan P., Higginbotham S., et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002, 23:1071-1077.
18. Chen W.Y., Manson J.E., Hankinson S.E., Rosner B., Holmes M.D., Willett W.C., et al. Unopposed estrogen therapy and the risk of invasive breast cancer. Archives of Internal Medicine 2006, 166:1027-1032.
19. Chetrite G.S., Cortes-Prieto J., Philippe J.C., Wright F., Pasqualini J.R. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. Journal of Steroid Biochemistry and Molecular Biology 2000, 72:23-27.
20. Chodosh L.A., D'Cruz C.M., Gardner H.P., Ha S.I., Marquis S.T., Rajan J.V., et al. Mammary gland development, reproductive history, and breast cancer risk. Cancer Research 1999, 59:1765s-1772s.
21. Clemons M., Goss P. Estrogen and the risk of breast cancer. New England Journal of Medicine 2001, 344:276-285.
22. Collins J.A., Blake J.M., Crosignani P.G. Breast cancer risk with postmenopausal hormonal treatment. Human Reproduction Update 2005, 11:545-560.
23. Courant F., Antignac J.-P., Maume D., Monteau F., Andre F., Le Bizec B. Determination of naturally occurring oestrogens and androgens in retail samples of milk and eggs. Food Additives and Contaminants 2007, 24:1358-1366.
24. Dorgan J.F., Longcope C., Stephenson H.E., Falk R.T., Miller R., Franz C., et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 1996, 5:533-539.
25. Dusterberg B., Schmidt-Gollwitzer M., Humpel M. Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women. Hormone Research 1985, 21:145-154.
26. Edery M., Goussard J., Dehennin L., Scholler R., Reiffsteck J., Drosdowsky M.A. Endogenous oestradiol-17β concentration in breast tumors determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. European Journal of Cancer 1981, 17:115-120.
27. Edlefsen K.L., Jackson R.D., Prentice R.L., Janssen I., Rajkovic A., O'Sullivan M.J., et al. The effect of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause 2010, 17:622-629.
28. Eliassen A.H., Hankinson S.E. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Advances in Experimental Medicine and Biology 2008, 630:148-165.
29. Eliassen A.H., Missmer S.A., Tworoger S.S., Hankinson S.E. Circulating 2-hydroxy- and 16α-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2008, 17:2029-2035.
30. Eliassen A.H., Ziegler R.G., Rosner B., Veenstra T.D., Roman J.M., Xu X., et al. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2009, 18:2860-2868.
31. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute 2002, 94:606-616. Endogenous Hormones and Breast Cancer Collaborative Group.
32. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute 2003, 95:1218-1226. Endogenous Hormones and Breast Cancer Collaborative Group.
33. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute 2008, 100:170-183. Endogenous Hormones and Prostate Cancer Collaborative Group.
34. Falany J.L., Falany C.N. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Research 1996, 56:1551-1555.
35. Farlow D.W., Xu X., Veenstra T.D. Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC-MS/MS. Journal of Chromatography B 2009, 877:1327-1334.
36. Ferguson D.J.P. Intraepithelial lymphocytes and macrophages in the normal breast. Virchows Archiv: Pathology and Anatomy 1985, 407:369-378.
37. Foster P.A., Newman S.P., Chander S.K., Stengel S.K., Jhalli R., Woo L.L.W., et al. In vivo efficacy of STX213, a second- generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy. Clinical Cancer Research 2006, 12:5543-5549.
38. Fung T.F., Hu F.B., Barbieri R.L., Willett W.C., Hankinson S.F. Dietary patterns, the alternate healthy index and plasma sex hormone concentrations in postmenopausal women. International Journal of Cancer 2007, 121:803-809.
39. Ganmaa D., Sato A. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses 2005, 65:1028-1037.
40. Ganmaa D., Wang P.Y., Qin L.Q., Hoshi K., Sato A. Is milk responsible for male reproductive disorders?. Medical Hypotheses 2001, 57:510-514.
41. Gaspard U.J., Dubois M., Gillain D., Franchimont P., Duvivier J. Ovarian function is effectively inhibited by a low dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Contraception 1984, 29:305-318.
42. Geisler J. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. Journal of Steroid Biochemistry and Molecular Biology 2003, 86:245-253.
43. Genkinger J.M., Hunter D.J., Spiegelman D., Anderson K.E., Arslan A., Beeson W.L., et al. Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiology, Biomarkers and Prevention 2006, 15:364-372.
44. Goldfien A., Monroe S.E. The ovaries. Basic and clinical endocrinology 1986, 385-430. Lange Medical Publications, Los Altos, CA, USA. 2nd ed. F.S. Greenspan, P.H. Forsham (Eds.).
45. Goldin B.R., Adlercreutz H., Dwyer J.T., Swenson L., Warram J.H., Gorbach S.L. Effect of diet on excretion of estrogens in pre- and postmenopausal women. Cancer Research 1981, 41:3771-3773.
46. Goldin B.R., Gorbach S.L. Hormone studies and the diet and breast cancer connection. Diet and breast cancer 1994, 35-46. Plenum Press, New York, NY, USA. American Institute for Cancer Research (Ed.).
47. Grodstein F., Martinez M.E., Platz E.A., Giovannucci E., Colditz G.A., Kautzky M., et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Annals of Internal Medicine 1998, 128:705-712.
48. Grodstein F., Newcomb P.A., Stampfer M.J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. American Journal of Medicine 1999, 106:574-582.
49. Grow D.R. Metabolism of endogenous reproductive hormones. Obstetrics and Gynecology Clinics of North America 2002, 29:425-436.
50. Gyawu P., Pope G.S. Post-partum, ovarian function in dairy cows as revealed by concentrations of oestradiol-17β and progesterone in defatted milk. British Veterinary Journal 1990, 146:194-204.
51. Hankinson S.E., Willett W.C., Manson J.E., Hunter D.J., Colditz G.A., Stampfer M.J., et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. Journal of the National Cancer Institute 1995, 87:1297-1302.
52. Harkonen P.L., Makela S.I. Role of estrogens in development of prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2004, 92:297-305.
53. Harris J.R., Lippman M.E., Veronesi U., Willett W. Breast cancer. New England Journal of Medicine 1992, 327:319-328.
54. Hartmann S., Lacorn M., Steinhart H. Natural occurrence of steroid hormones in food. Food Chemistry 1998, 62:7-20.
55. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiology, Biomarkers and Prevention 1998, 7:653-659.
56. Henderson K.M., Camberis M., Simmons M.H., Starrs W.J., Hardie A.H.M. Application of enzymeimmunoassay to measure oestrone sulphate concentrations in cows' milk during pregnancy. Journal of Steroid Biochemistry 1994, 50:189-196.
57. Henderson K.M., Karanikolas M., Kenealy L., Macmillan K.L. Concentrations of oestrone sulphate during pregnancy in milk from Jersey and Friesian dairy cows differing in milk yield and composition. New Zealand Veterinary Journal 1994, 42:89-92.
58. Hoffmeister M., Raum E., Krtschil A., Chang-Claude J., Brenner H. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clinical Pharmacology and Therapeutics 2009, 86:416-424.
59. Holt P.R. New insights into calcium, dairy and colon cancer. World Journal of Gastroenterology 2008, 14:4429-4433.
60. Hsueh A.J.W., Billig H. Ovarian hormone synthesis and mechanism of action. Endocrinology 1995, 2019-2030. W. B. Saunders Company, Philadelphia, PA, USA. 3rd ed. L.J. DeGroot (Ed.).
61. Huncharek M., Muscat J., Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutrition and Cancer 2009, 61:47-69.
62. Hunter D.J., Colditz G.A., Hankinson S.E., Malspeis S., Spiegelman D., Chen W., et al. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiology, Biomarkers and Prevention 2010, 19:2496-2502.
63. Ito K., Utsunomiya H., Yaegashi N., Sasano H. Biological roles of estrogens and progesterone in human endometrial carcinoma - new developments in potential endocrine therapy for endometrial cancer. Endocrine Journal 2007, 54:667-679.
64. Kaaks R., Lukanova A., Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology, Biomarkers and Prevention 2002, 11:1531-1543.
65. Kahlenborn C., Modugno F., Potter D.M., Severs W.B. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clinic Proceedings 2006, 81:1290-1302.
66. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005, 26:833-876.
67. Kelly P.M.A., Davison R.S., Bliss E., McGee O'D. Macrophages in human breast disease: a quantitative immunohistochemical study. British Journal of Cancer 1988, 57:174-177.
68. Key T.J.A., Wang D.Y., Brown J.B., Hermon C., Allen D.S., Moore J.W., et al. A prospective study of urinary oestrogen excretion and breast cancer risk. British Journal of Cancer 1996, 73:1615-1619.
69. Khan S.A., Sachdeva A., Naim S., Meguid M.M., Marx W., Simon H., et al. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:867-872.
70. Koralek D.O., Bertone-Johnson E.R., Leitzmann M.F., Sturgeon S.R., Lacey J.V., Schairer C., et al. Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutrition and Cancer 2006, 56:22-30.
71. Kuhnz W., Gansau C., Mahler M. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung 1993, 43:966-973.
72. Kuller L.H. The etiology of breast cancer - from epidemiology to prevention. Public Health Reviews 1995, 23:157-213.
73. Labrie F. Intracrinology. Molecular and Cellular Endocrinology 1991, 78:C113-C118.
74. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Annales d'Endocrinologie 2003, 64:95-107.
75. Labrie F., Luu-The V., Labrie C., Belanger A., Simard J., Lin S.-X., et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews 2003, 24:152-182.
76. LaCroix A.Z., Chlebowski R.T., Manson J.E., Aragaki A.K., Johnson K.C., Martin L., et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy. Journal of the American Medical Association 2011, 305:1305-1314.
77. Lakhani N.J., Sarkar M.A., Venitz J., Figg W.D. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003, 23:165-172.
78. van Landeghem A.A.J., Poortman J., Nabuur M., Thijssen J.H.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Research 1985, 45:2900-2906.
79. Larionov A.A., Berstein L.M., Miller W.R. Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues. Journal of Steroid Biochemistry and Molecular Biology 2002, 81:57-64.
80. Larsson S.C., Bergkvist L., Wolk A. High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. American Journal of Clinical Nutrition 2005, 82:894-900.
81. Liehr J.C. Is estradiol a genotoxic mutagenic carcinogen?. Endocrine Reviews 2000, 21:40-54.
82. Linos E., Willett W.C., Cho E., Frazier L. Adolescent diet in relation to breast cancer risk among premenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2010, 19:689-696.
83. Lobo R.A., Cassidenti D.L. Pharmacokinetics of oral 17β-estradiol. Journal of Reproductive Medicine 1992, 37:77-84.
84. Longcope C., Gorbach S., Goldin B., Woods M., Dwyer J., Warram J. The metabolism of estradiol; oral compared to intravenous administration. Journal of Steroid Biochemistry 1985, 23:1065-1070.
85. Lukanova A., Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:98-107.
86. Lukanova A., Lundin E., Michel A., Arslan A., Ferrari P., Rinaldi S., et al. Circulating levels of sex hormones and risk of endometrial cancer in postmenopausal women. International Journal of Cancer 2004, 108:425-432.
87. McCullough M.L., Rodriguez C., Diver W.R., Feigelson H.S., Stevens V.L., Thun M.J., et al. Dairy, calcium and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:2898-2904.
88. Malekinejad H., Scherpenisse P., Bergwerff A.A. Naturally occurring estrogens in processed milk and in raw milk (from gestated cows). Journal of Agricultural and Food Chemistry 2006, 54:9785-9791.
89. Maruyama K., Oshima T., Ohyama K. Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows. Pediatrics International 2010, 52:33-38.
90. Masamura S., Santner S.J., Santen R.J. Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase. Journal of Steroid Biochemistry and Molecular Biology 1996, 58:425-429.
91. Michel K.B., Rosner B.A., Chumlea W.C., Colditz G.A., Willett W.C. Preschool diet and adult risk of breast cancer. International Journal of Cancer 2006, 118:749-754.
92. Miller W.R., Telford J., Love C., Leonard R.C.F., Hillier S., Gundacker H., et al. Effects of letrozole as primary medical therapy on in situ oestrogen synthesis and endogenous oestrogen levels within the breast. Breast 1998, 7:273-276.
93. Missmer S.A., Smith-Warner S.A., Spiegelman D., Yaun S.-S., Adami H.-O., Beeson W.L., et al. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. International Journal of Epidemiology 2002, 31:78-85.
94. Mommers M., Schouten L.J., Goldbohm R.A., van den Brandt P.A. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. British Journal of Cancer 2006, 94:165-170.
95. Monk E.L., Erb R.E., Mollett T.A. Relationships between immunoreactive estrone and estradiol in milk, blood, and urine of dairy cows. Journal of Dairy Science 1975, 58:34-40.
96. Moorman P.G., Terry P.D. Consumption of dairy products and the risk of breast cancer: a review of the literature. American Journal of Clinical Nutrition 2004, 80:5-14.
97. Mor G., Yue W., Santen R.J., Gutierrez L., Eliza M., Bernstein L.M., et al. Macrophages, estrogen and the microenvironment of breast cancer. Journal of Steroid Biochemistry and Molecular Biology 1998, 67:403-411.
98. Mueck A.O., Seeger H., Lippert T.H. Estradiol metabolism and malignant disease. Maturitas 2002, 43:1-10.
99. O'Brien S.N., Anandjiwala J., Price T.M. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use. Obstetrics and Gynecology 1997, 90:244-248.
100. O'Dell W.D. The menopause and hormone replacement. Endocrinology 1995, 2128-2139. W. B. Saunders Company, Philadelphia, PA, USA. 3rd ed. L.J. DeGroot (Ed.).
101. Onland-Moret N.C., Kaaks R., van Noord P.A.H., Rinaldi S., Key T., Grobbee D.E., et al. Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. British Journal of Cancer 2003, 88:1394-1399.
102. Outwater J.L., Nicholson A., Barnard N. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 1997, 48:453-461.
103. Pala V., Krogh V., Berrino F., Sieri S., Grioni S., Tjonneland A., et al. Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. American Journal of Clinical Nutrition 2009, 90:602-612.
104. Pape-Zambito D.A., Magliaro A.L., Kensinger R.S. Concentrations of 17β-estradiol in Holstein whole milk. Journal of Dairy Science 2007, 90:3308-3313.
105. Pape-Zambito D.A., Magliaro A.L., Kensinger R.S. 17β-Estradiol and estrone concentrations in plasma and milk during bovine pregnancy. Journal of Dairy Science 2008, 91:127-135.
106. Pape-Zambito D.A., Roberts R.F., Kensinger R.S. Estrone and 17β-estradiol concentrations in pasteurized-homogenized milk and commercial dairy products. Journal of Dairy Science 2010, 93:2533-2540.
107. Parodi P.W. Cows' milk fat components as potential anticarcinogenic agents. Journal of Nutrition 1997, 127:1055-1060.
108. Parodi P.W. Dairy product consumption and the risk of breast cancer. Journal of the American College of Nutrition 2005, 24:556S-568S.
109. Parodi P.W. A role for milk proteins and their peptides in cancer prevention. Current Pharmaceutical Design 2007, 13:813-828.
110. Parodi P.W. Dairy product consumption and the risk of prostate cancer. International Dairy Journal 2009, 19:551-565.
111. Pasqualini J.R. The selective estrogen enzyme modulators in breast cancer: a review. Biochimica et Biophysica Acta 2004, 1654:123-143.
112. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.-C., Delalononde L., Talbi M., et al. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 1996, 81:1460-1464.
113. Perel E., Wilkins D., Killinger D.W. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. Journal of Steroid Biochemistry 1980, 13:89-94.
114. Pike M.C., Spicer D.V., Dahmoush L., Press M.F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 1993, 15:17-35.
115. van der Pols J.C., Bain C., Gunnell D., Davey Smith G., Frobisher C., Martin R.M. Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort. American Journal of Clinical Nutrition 2007, 86:1722-1729.
116. Potter J.D. Hormones and colon cancer. Journal of the National Cancer Institute 1995, 87:1039-1040.
117. Prentice R.L., Caan B., Chlebowski R.T., Patterson R., Kuller L.H., Ockene J.K., et al. Low-fat dietary pattern and risk of invasive breast cancer. Journal of the American Medical Association 2006, 295:629-642.
118. Pufulete M. Intake of dairy products and risk of colorectal neoplasia. Nutrition Research Reviews 2008, 21:56-67.
119. Purohit A., Woo L.W.L., Potter B.V.L., Reed M.J. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE. Cancer Research 2000, 60:3394-3396.
120. Qian Y., Deng C., Song W.-C. Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. Journal of Pharmacology and Experimental Therapeutics 1998, 286:555-560.
121. Qin L.-Q., Wang P.-Y., Kaneko T., Hoshi K., Sato A. Estrogen: one of the risk factors in milk for prostate cancer. Medical Hypotheses 2004, 62:133-142.
122. Reed M.J., Owen A.M., Lai L.C., Coldham N.G., Ghilchik M.W., Shaikh N.A., et al. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. International Journal of Cancer 1989, 44:233-237.
123. Risbridger G.P., Bianco J.J., Ellem S.J., McPherson S.J. Oestrogens and prostate cancer. Endocrine-Related Cancer 2003, 10:187-191.
124. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. Journal of the National Cancer Institute 1998, 90:1774-1786.
125. Rogan E.G., Badawi A.F., Devanesan P.D., Meza J.L., Edney J.A., West W.W., et al. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma; potential biomarkers of susceptibility to cancer. Carcinogenesis 2003, 24:697-702.
126. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kopperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Journal of the American Medical Association 2002, 288:321-333.
127. Sangsritavong S., Combs D.K., Sartori R., Armentano L.E., Wiltbank M.C. High feed intake increases liver blood flow and metabolism of progesterone and estradiol-17β in dairy cattle. Journal of Dairy Science 2002, 85:2831-2842.
128. Santen R.J. To block estrogen's synthesis or action: that is the question. Journal of Clinical Endocrinology and Metabolism 2002, 87:3007-3012.
129. Santner S.J., Feil P.D., Santen R.J. In situ estrogen production via the estrone sulfatase pathway in breast tumours: relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism 1984, 59:29-33.
130. Sasano H., Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Reviews 1998, 19:593-607.
131. Schmidt M., Kreutz M., Loffler G., Scholmerich J., Straub R.H. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. Journal of Endocrinology 2000, 164:161-169.
132. Sieri S., Krogh V., Bolelli G., Abagnato C.A., Grioni S., Pala V., et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiology, Biomarkers and Prevention 2009, 18:169-176.
133. Smirnoff P., Liel Y., Gnainsky J., Shany S., Schwartz B. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncology Research 1999, 11:255-264.
134. Soderqvist G., von Schoultz B., Tani E., Skoog L. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. American Journal of Obstetrics and Gynecology 1993, 168:874-879.
135. Stanway S.J., Purohit A., Woo L.W.L., Sufi S., Vigushin D., Ward R., et al. Phase 1 study of STX 64 (667 coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clinical Cancer Research 2006, 12:1585-1592.
136. Suzuki T., Nakata T., Miki Y., Kaneko C., Moriya T., Ishida T., et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Research 2003, 63:2762-2770.
137. Taioli E., Im A., Xu X., Veenstra T.D., Ahrendt G., Garte S. Comparison of estrogens and estrogen metabolites in human breast tissue and urine. Reproductive Biology and Endocrinology 2010, 8:93.
138. Takase Y., Levesque M.-H., Luu-The V.L., El-Alfy M., Labrie F., Pelletier G. Expression of enzymes involved in estrogen metabolism in human prostate. Journal of Histochemistry and Cytochemistry 2006, 54:911-921.
139. Thijssen J.H.H., van Landeghem A.A.J., Poortman J. Uptake and concentration of steroid hormones in mammary tissue. Annals of the New York Academy of Sciences 1986, 464:106-116.
140. Vicini J., Etherton T., Kris-Etherton P., Ballam J., Denham S., Staub R., et al. Survey of retail milk composition as affected by label claims regarding farm-management practices. Journal of the American Dietetic Association 2008, 108:1198-1203.
141. Weige C.C., Allred K.F., Allred C.D. Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Research 2009, 69:9118-9124.
142. Food, nutrition, physical activity, and the prevention of cancer: A global perspective 2007, World Cancer Research Fund/American Institute for Cancer Research, AICR, Washington, DC, USA.
143. Evaluation of certain veterinary drug residues in food. Joint WHO/FAO Expert Committee on Food Additives 2000, World Health Organization, WHO Technical Report Series No. 893, WHO, Geneva, Switzerland.
144. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. New England Journal of Medicine 2006, 354:270-282.
145. Yue W., Santen R.J., Li Y., Verdertame M.F., Bocchinfuso W.P., Korach K.S., et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. Journal of Steroid Biochemistry and Molecular Biology 2003, 86:477-486.
146. Yue W., Wang J.-P., Hamilton C.J., Demers L.M., Santen R.J. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Research 1998, 58:927-932.